• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Silo Pharma Inc (NQ: SILO )

    0.9550 +0.0100 (+1.06%)
    Streaming Delayed Price Updated: 12:58 PM EDT, Jul 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 36,535
    Open 0.9200
    Bid (Size) 1.000 (10)
    Ask (Size) 1.030 (10)
    Prev. Close 0.9450
    Today's Range 0.9200 - 0.9700
    52wk Range 0.9100 - 3.050
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Collaborates with CRO Partner to Advance SPC-15 for PTSD
    Via Investor Brand Network
    Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety
    From Silo Pharma, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -37.17%
    -37.17%
    1 Month
    -52.96%
    -52.96%
    3 Month
    -50.77%
    -50.77%
    6 Month
    -33.22%
    -33.22%
    1 Year
    -53.41%
    -53.41%

    More News

    Read More
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Closes on $2M Registered Direct Offering, Provides Update on SP-26 Ketamine Implant Therapeutic
    Via Investor Brand Network
    Why Silo Pharma Stock Is Down Over 30%
    Via Benzinga
    Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Crude Oil Rises 1%; Dollar Tree Shares Fall After Q1 Results
    Via Benzinga
    Exposures Fossil Fuels
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters Registered Direct Offering Estimated to Reach $2M
    Via Investor Brand Network
    Gold Gains 1%; ISM Services PMI Surges In May
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
    From Silo Pharma, Inc.
    Via GlobeNewswire
    InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Pre-IND Submission for Proprietary Treatment for PTSD, Anxiety
    Via Investor Brand Network
    Exposures Product Safety
    Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Silo Pharma’s (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors
    Via AB Newswire
    Exposures Product Safety
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Shares ‘Significant Development’ in Depression Study Showing Potential to Extend Remission Period, Prevent Relapse
    Via Investor Brand Network
    Silo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse Prevention
    From Silo Pharma, Inc.
    Via GlobeNewswire
    BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Announces Participation in FDA Event Exploring Emerging Therapeutic Interest in Ketamine
    Via Investor Brand Network
    Exposures Product Safety
    Silo Pharma to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine
    From Silo Pharma, Inc.
    Via GlobeNewswire
    InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Shares Positive Results for PTSD Treatment
    Via Investor Brand Network
    Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.